Quarterly report pursuant to Section 13 or 15(d)

Supplemental Balance Sheet Information

v3.23.1
Supplemental Balance Sheet Information
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Balance Sheet Information
7.
Supplemental Balance Sheet Information

Accrued expenses and other current liabilities consist of the following:

 

 

 

March 31,
2023

 

 

December 31,
2022

 

Accrued consulting

 

$

423,464

 

 

$

232,390

 

Accrued compensation

 

 

283,657

 

 

 

459,997

 

Accrued research and development

 

 

851,000

 

 

 

1,696,129

 

Accrued other

 

 

100

 

 

 

9,920

 

Total accrued expenses and other current liabilities

 

$

1,558,221

 

 

$

2,398,436